Grants and Contributions:
Title:
AI strategy for the generation of compounds optimized for activity, toxicity, and synthetic feasibility
Agreement Number:
952443
Agreement Value:
$315,000.00
Agreement Date:
Jun 29, 2020 - Nov 30, 2021
Description:
We propose new artificial intelligence strategies for optimizing the molecular structures of pre-clinical drug candidates against multiple biological properties and ease of synthesis.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H2S 3G9
Reference Number:
172-2020-2021-Q2-952443
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
759660087
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 95 days.
Amendment Date
Aug 26, 2021
Recipient's Legal Name:
10736406 CANADA INC.
Federal Riding Name:
Rosemont--La Petite-Patrie
Federal Riding Number:
24064
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
511211
Amendments: